Cardiotext Logo
Hello, Guest.
Cardiotext Rewards Program Free Shipping on domestic orders of $99.00 or more McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
Product Detail

Cardiovascular Pharmacotherapeutics

WIlliam H. Frishman; Edmund Sonnenblick


Shipping Calculator

Request a Quote for 10+ Copies

Tell A Friend

More Info...
Cardiovascular Pharmacotherapeutics Retail Price: $178.00
Cardiotext Price: $174.44

Availability: Usually ships within 2-3 business days. Rush shipping available.

Product Information:
ISBN-13: 9780071369817
ISBN-10: 0071369813
Publisher: McGraw-Hill Professional
Format: Hardback, 1072 pages
Pub Date: 11/2002
Edition Number: 2




Synopsis

EVERYTHING PRACTICING PHYSICIANS AND PHARMACISTS NEED TO KNOW ABOUT DRUG THERAPY FOR HEART CONDITIONS

The updated Second Edition of this classic brings you fully up to speed on…


All the cardiovascular agents now available
Mechanisms of action of cardiovascular pharmacotherapeutics
Specific drug treatments
Drugs in development
Molecular biological advances
More

A compendium of valuable, updated pharmacotherapeutic information for managing patients with cardiovascular disease

Cardiovascular Pharmacotherapeutics has long been considered the primary reference for practicing physicians and pharmacists who need to know about drug therapy for heart conditions. This new Second Edition keeps pace with the latest drug discoveries and new therapeutic agents -- a task that challenges even specialists in the field.

Contributions from many of the leading investigators in cardiovascular pathophysiology and drug development

This timely second edition, primarily oriented toward specific drugs and drug classes, is co-edited and co-authored by three distinguished physician-scientists with important research accomplishments in cardiovascular pharmacology and pathophysiology. They provide you with:
An understanding of all presently available cardiovascular agents
The scientific basis behind every pharmacotherapy advance
Hands-on discussions of how to utilize specific drugs for treatment of various cardiovascular disorders and for the prevention of disease
Information about recently approved drugs that were only pharmacologic concepts in the previous edition
Detailed discussion of drugs in development and potential drug targets for innovative drug discovery – outgrowths of advances in knowledge of receptor and ion channel biology, cell growth, neurohumoral control, biochemistry and pathophysiology
More

Significant Features of the Second Edition


New section on New Drug Classes in De velopment keeps you abreast of this fast-evolving therapeutic area
Special Topics section provides additional information on drug-drug interactions, the use of cardiovascular drugs in children, the treatment of peripheral vascular disease, complementary medicine, and quality of life issues
Appendices provide you with practical, hands-on information on drug utilization in clinical practice




Similar Items



Customer Reviews
Be the first to review this product



Browse Titles In Related Subjects

Additional Description

Part 1 Introductory Chapters

1.* Basic Principles
2.* Placebo Effect
3.* Compliance
4.* New Drug Development
5.* Pharmacoeconomics
6.* Cardiovascular Pharm History

Part 2 Drug Classes

7. Alpha & Beta blockers
8. Cholinergic & Anticholinergic Drugs
9. Calcium blockers
10. RAS – ACE, ARBs
11. Diuretic
12. Mag, K+, Calcium
13. Digitalis and Inotropic Agents
14.* Organic Nitrates and nitroprusside
15.* Central Action, Ganglionic blockers, neuron depletors
16.* Nonspecific antihypertensive vasodilators
17. Antiarrhythmics
18.* Antiplatelets & Antithrombotics
19.* Thrombolytics
20. Lipid lowering/effects of CV drugs on lipoproteins
21.* Combination
22.* Smoking, nicotine
23. Fish oils
24. Antioxidant vitamins and free radical scavengers
25.* Prostacyclin
26 . Dopamine

Part 3 New Drugs Classes in Development

27. Natriuretic peptides and neutral endopeptidase
28.* Potassium channel and sodium-hydrogen channel
29.* Serotonin
30.* Imidazoline
31*. Endothelin
32.* Adenosine
33.* Nitric oxide
34.* Renin
35.* Vasopressin
36.* Hormones
37.* Innovative approaches for myocardial ischemia – focus on angiogenesis
38.* Angiogenesis
39.* Innovative drug targets
40. Restenosis
41.* Gene therapy
42. Apoptosis
43.* Matrix Metalloproteinase
44. NSAIDS & Cox 2 inhibitors
45. Prostaglandins & P450 Metabolites
46.* Innovative med. approaches to hyperlipidemia